v3.26.1
Equity - Accumulated Other Comprehensive Income/(Loss) (Net of Tax) (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Net other comprehensive income(loss) after tax $ 757    
Foreign Currency Translation Adjustments [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance (2,857) $ (2,384) $ (2,514)
Other comprehensive income (loss) before reclassifications 569 (456) 167
Release of cumulative translation adjustments [1] 181    
Net other comprehensive income(loss) before tax 750 (456) 167
Corresponding income tax (45) (17) (37)
Net other comprehensive income(loss) after tax [2] 705 (473) 130
Ending Balance (2,152) (2,857) (2,384)
Derivative Financial Instruments [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance (238) (266) (295)
Other comprehensive income (loss) before reclassifications 4   (1)
Amounts reclassified to the statements of income 35 28 30
Net other comprehensive income(loss) before tax 39 28 29
Net other comprehensive income(loss) after tax [2] 39 28 29
Ending Balance (199) (238) (266)
Benefit Plans [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance (52) (46) (28)
Other comprehensive income (loss) before reclassifications 3 (1) (17)
Amounts reclassified to the statements of income 12 (6) (4)
Net other comprehensive income(loss) before tax 15 (7) (21)
Corresponding income tax (2) 1 3
Net other comprehensive income(loss) after tax [2] 13 (6) (18)
Ending Balance (39) (52) (46)
AOCI Attributable to Parent [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Beginning Balance (3,148) (2,697) (2,838)
Other comprehensive income (loss) before reclassifications 572 (457) 149
Amounts reclassified to the statements of income 51 22 26
Release of cumulative translation adjustments [1] 181    
Net other comprehensive income(loss) before tax 804 (434) 175
Corresponding income tax (47) (16) (34)
Net other comprehensive income(loss) after tax [2] 757 (450) 141
Ending Balance $ (2,391) $ (3,148) $ (2,697)
[1] In connection with the sale of Teva’s business venture in Japan.
[2] Amounts do not include $27 million gain in 2025, $61 million loss in 2024 and $50 million loss in 2023 from foreign currency translation adjustments attributable to redeemable and non-redeemable non-controlling interests.